With a vast patient pool, feasible timelines for approval, and written procedures for submission to ethics committees and regulatory authorities, there is wide scope for …
China makes up 19% of the world’s population, and is expected to overtake the US as the world’s largest market by 2020, putting it right …
It is well-established that patients with chronic kidney disease (CKD) have a significantly higher cardiovascular risk than those with normal renal function. In fact, the …
Meg Egan Auderset of Thomson Reuters explains the Final FDA guidance released in January 2014, which outlines the formal qualification process for drug development tools …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
